logo

For the Inventor, By the Inventor

Ikoma, Japan

Kazunori Ohno

This inventor holds 8 USPTO granted patents. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1989-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazunori Ohno. Retrieved from https://idiyas.com/inventor/kazunori-ohno-nsh083c6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8

% Patents Active = 75.0

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 26(Granted Patents)


Location History:

  • Higashi-Osaka, JP (1989 - 1995)
  • Ikoma, JP (2001 - 2004)

Company Filing History:

goldMedal8 out of 129 
 
Dainippon Pharmaceutical Company, Limited
 patents

Years Active: 1989-2004

Loading Chart...
8 patents (USPTO):Explore Patents
1. 6743803 - Medicines for the prevention and treatment of neurodegenerative diseases (2004-06-01),
2. 6620817 - [5-CHLORO-6-PHENYL-2-(4-TRIFLUOROMETHYLPHENYL)-4-PYRIMIDINYLAMINO]ACETAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATE OF THESE COMPOUNDS (2003-09-16),
3. 6277993 - Intermediates for 5-substituted-3-oxadiazolyl-1,6-Naphthyridin-2(1H)-one derivatives (2001-08-21),
4. 6172079 - 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivatives (2001-01-09),
5. 5424434 - Production on 3-oxadiazolyl-1,6-naphthyridine derivatives (1995-06-13),
6. 5424433 - Intermediates for 3-oxadiazoly-1,6-naphthyridine derivatives (1995-06-13),
7. 5367078 - 3-oxadiazolyl-1,6-naphthyridine derivatives (1994-11-22),
8. 4870074 - Substituted benzamide derivatives, for enhancing gastrointestinal (1989-09-26),

Title: Kazunori Ohno: Innovator in Neurodegenerative Disease Treatment

Introduction

Kazunori Ohno is a prominent inventor based in Ikoma, Japan. He has made significant contributions to the field of medicine, particularly in the prevention and treatment of neurodegenerative diseases. With a total of eight patents to his name, Ohno's work is recognized for its potential impact on healthcare.

Latest Patents

One of Kazunori Ohno's latest patents focuses on medicines for the prevention and treatment of neurodegenerative diseases. This patent includes the compound 5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinylamino acetamide derivatives, along with the processes for producing these compounds and medicinal compositions containing them. This innovative approach aims to provide new therapeutic options for patients suffering from these debilitating conditions.

Career Highlights

Kazunori Ohno is currently associated with Dainippon Pharmaceutical Company, Limited, where he continues to advance his research and development efforts. His career is marked by a commitment to improving medical treatments and enhancing patient outcomes through innovative solutions.

Collaborations

Throughout his career, Ohno has collaborated with notable colleagues, including Kiyoshi Furukawa and Osamu Odai. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Kazunori Ohno's contributions to the field of medicine, particularly in neurodegenerative disease treatment, highlight his role as an influential inventor. His ongoing work and collaborations continue to pave the way for advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…